GoHealth price target raised to $12 from $8 at RBC Capital

RBC Capital raised the firm’s price target on GoHealth (GOCO) to $12 from $8 and keeps a Sector Perform rating on the shares. The firm is updating its model with a roll in valuation after the company’s Q2 results while noting that the recent credit transactions enhance flexibility ahead of AEP – Annual Enrollment Period – and capacity for potential M&A, the analyst tells investors in a research note.